1. Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
   Xuyao Zhang et al, 2017, Cancer Immunology Research CrossRef
2. LncRNA MALAT-1 modulates EGFR-TKI resistance in lung adenocarcinoma cells by downregulating miR-125
   Jie Luo et al, 2024, Discover Oncology CrossRef
3. CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer
   Xiaoyu Zhou et al, 2017, Disease Markers CrossRef
4. Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group
   Nam P. Nguyen et al, 2020, Cancers CrossRef
5. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer
   Xiang Cao et al, 2017, Oncotarget CrossRef
6. Alveolar architectures preserved in cancer tissues may be potential pitfalls for diagnosis and histological subtyping of lung cancer
   Xiaoxi Fan et al, 2018, Medicine CrossRef
7. Potential Epigenetic-Based Therapeutic Targets for Glioma
   Lanlan Zang et al, 2018, Frontiers in Molecular Neuroscience CrossRef
8. Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer
   Ke Wang et al, 2017, Oncotarget CrossRef
9. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy
   Min Zhao et al, 2021, European Journal of Medicinal Chemistry CrossRef